Effectiveness of add-on stiripentol to clobazam and valproate in Japanese patients with Dravet syndrome: Additional supportive evidence
Authors:
- 1 May 2014
- journal article
- clinical trial
- Published by Elsevier in Epilepsy Research
- Vol. 108 (4) , 725-731
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A long‐term follow‐up study of Dravet syndrome up to adulthoodEpilepsia, 2010
- Stiripentol open study in Japanese patients with Dravet syndromeEpilepsia, 2009
- Management of and prophylaxis against status epilepticus in children with severe myoclonic epilepsy in infancy (SMEI; Dravet syndrome) – A nationwide questionnaire survey in JapanBrain and Development, 2008
- Severe myoclonic epilepsy in infancy: A systematic review and a meta‐analysis of individual patient dataEpilepsia, 2007
- StiripentolNeurotherapeutics, 2007
- IN VITRO AND IN VIVO INHIBITORY EFFECT OF STIRIPENTOL ON CLOBAZAM METABOLISMDrug Metabolism and Disposition, 2006
- Changes in plasma protein binding have little clinical relevanceClinical Pharmacology & Therapeutics, 2002
- Severe myoclonic epilepsy in infants – a review based on the Tokyo Women's Medical University series of 84 casesBrain and Development, 2001
- Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trialThe Lancet, 2000
- Stiripentol in Atypical Absence Seizures in Children: An Open TrialEpilepsia, 1993